These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17237065)

  • 1. Peak selection from MALDI-TOF mass spectra using ant colony optimization.
    Ressom HW; Varghese RS; Drake SK; Hortin GL; Abdel-Hamid M; Loffredo CA; Goldman R
    Bioinformatics; 2007 Mar; 23(5):619-26. PubMed ID: 17237065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker selection and sample prediction for multi-category disease on MALDI-TOF data.
    Oh JH; Kim YB; Gurnani P; Rosenblatt KP; Gao JX
    Bioinformatics; 2008 Aug; 24(16):1812-8. PubMed ID: 18562269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of mass spectral serum profiles for biomarker selection.
    Ressom HW; Varghese RS; Abdel-Hamid M; Eissa SA; Saha D; Goldman L; Petricoin EF; Conrads TP; Veenstra TD; Loffredo CA; Goldman R
    Bioinformatics; 2005 Nov; 21(21):4039-45. PubMed ID: 16159919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.
    Paradis V; Degos F; Dargère D; Pham N; Belghiti J; Degott C; Janeau JL; Bezeaud A; Delforge D; Cubizolles M; Laurendeau I; Bedossa P
    Hepatology; 2005 Jan; 41(1):40-7. PubMed ID: 15690480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma.
    Orvisky E; Drake SK; Martin BM; Abdel-Hamid M; Ressom HW; Varghese RS; An Y; Saha D; Hortin GL; Loffredo CA; Goldman R
    Proteomics; 2006 May; 6(9):2895-902. PubMed ID: 16586431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
    J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments.
    Harezlak J; Wang M; Christiani D; Lin X
    Bioinformatics; 2007 Sep; 23(18):2441-8. PubMed ID: 17626063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strategy for the prior processing of high-resolution mass spectral data obtained from high-dimensional combined fractional diagonal chromatography.
    Valkenborg D; Thomas G; Krols L; Kas K; Burzykowski T
    J Mass Spectrom; 2009 Apr; 44(4):516-29. PubMed ID: 19065607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra.
    Mantini D; Petrucci F; Del Boccio P; Pieragostino D; Di Nicola M; Lugaresi A; Federici G; Sacchetta P; Di Ilio C; Urbani A
    Bioinformatics; 2008 Jan; 24(1):63-70. PubMed ID: 18003646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of early relapse in ovarian cancer using serum proteomic profiling.
    Oh JH; Gao J; Nandi A; Gurnani P; Knowles L; Schorge J
    Genome Inform; 2005; 16(2):195-204. PubMed ID: 16901102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
    He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
    J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma.
    Ressom HW; Varghese RS; Goldman L; An Y; Loffredo CA; Abdel-Hamid M; Kyselova Z; Mechref Y; Novotny M; Drake SK; Goldman R
    J Proteome Res; 2008 Feb; 7(2):603-10. PubMed ID: 18189345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
    Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
    Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.